An infallible advocate for robust data-driven development of Cell & Gene Therapies, Jon is a cell biologist with 20 years’ experience in the production, development, and manufacturing establishment of Cell, Gene and Tissue therapies. His expertise spans R&D into new modality therapeutics and production processes, novel technology development for Cell Therapy manufacture, and the establishment through ongoing management of GMP biologic manufacturing.
Jon previously managed the US operations of a global Cell Therapy consulting business, leading a process development team and translation lab assessing and refining client manufacturing processes across novel automation pathways. Early in his career in the UK, Jon managed a large-scale cord blood and bone marrow transplantation laboratory, overseeing the delivery of GMP cell therapeutics to patients across 10 years. He moved to the US to focus on the development of new technologies for Cell & Gene Therapy manufacturing.
An author on multiple patents, Jon thrives at the intersection of process and product development for Cell & Gene Therapies, transitioning emerging novel technologies to market application. He brings first-hand experience across isolation, gene modification and expansion of cell types including T, NK, CD34, and MSCs, and has developed processes using today’s state of the art of Cell & Gene Therapy manufacturing systems. Jon has collaborated with many of the world’s leading therapy developers, from start-ups to multinationals, and is driven to elevate the manufacturing of Cell & Gene Therapies by automating and simplifying production processes to improve patient.